Pascal Birman - University of California, San Diego

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

An Open Label, Randomized, Multicenter Study of Elafibranor in Children with Nonalcoholic Steatohepatitis

Nidhi P. P. Goyal,Ali Mencin,Kimberly P. P. Newton,Janis Durelle,Carissa Carrier,Patricia Ugalde-Nicalo,Benoit Noel,Julie Mouton,Dawn Vargas,David Magrez,Bachirou Tadde,Pascal Birman,Brookie M. M. Best,Carol Addy,Jeffrey B. B. Schwimmer

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITIONno. 2 (2023): 160-165

引用2浏览0WOS引用

PHARMACOKINETICS AND SAFETY OF ELAFIBRANOR IN SUBJECTS WITH IMPAIRED HEPATIC FUNCTION

Benoit Noel,Dawn Vargas, Anne Georges-Coty,Alice Roudot, Olivier Roux,David Magrez,David Wyatt,Pascal Birman,Carol Addy

HEPATOLOGY（2021）

引用0浏览0引用

One-year changes in histological nash activity scores are correlated with changes in fibrosis and glucose metabolism markers

Vlad Ratziu,Stephen A. Harrison,Sven M. Francque,Quentin M. Anstee,Pierre Bedossa,Noemie Dam,Jeremy Magnanensi,Yacine Hajji,Alice Roudot,Bart Staels,Dean W. Hum,Pascal Birman,Remy Hanf,Arun J. Sanyal

HEPATOLOGY（2020）

引用0浏览0引用

Attribution of Nonalcoholic Steatohepatitis As an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum

Mazen Noureddin,Jean L. Chan,Katherine Barradas,Lara Dimick-Santos,Elmer Schabel,Stephanie O. Omokaro,Frank A. Anania,Robert P. Myers,Veronica Miller,Arun J. Sanyal,Naga Chalasani,Jasmohan Bajaj,Annalisa Berzigotti,Pascal Birman,Jaime Bosch, Ashley Brower, Dania Calboli, William Charlton,Klara Dickinson,Claudia Filozof,Mikael F. Forsgren,Michael Fuchs,Guadalupe Garcia-Tsao,Juan Gonzalez-Abraldes,Hans-Juergen Gruss, Morten Hansen, Suneil Hosman,Joanne Imperial,David Jones,Gadi Lalazar,Olof Dahlqvist Leinhard,Erica Lyons, Brian McColgan,Ruby Mehta,Peter Mesenbrink,Rob Myers, Veronica Pei,Vlad Ratziu,Arie Regev, Robert Riccio,Arun Sanyal, Suna Seo,Alastair Smith,Peter Szitanyi,Peter Traber

Gastroenterology（2020）

引用16浏览0WOS引用

278-LB: Type 2 Diabetes (T2D) As a Risk Factor for NASH and Significant Liver Fibrosis (F>2) in an International Cohort of 2,363 Patients with Metabolic Steatosis

Bart Staels,Vlad Ratziu,Arun J. Sanyal,Sven Francque,Stephen A. Harrison,Alice Roudot,John Brozek,Yacine Hajji,Sophie Megnien,Dean W. Hum,Pascal Birman,Remy Hanf,Bertrand Cariou

Diabetes（2019）

引用0浏览0引用

ELAFIBRANOR AND NITAZOXANIDE HAVE COMPLEMENTARY ACTIONS TO PROTECT AGAINST OXIDATIVE STRESS IN NASH

Corinne Foucart,Nicolas Stankovic-Valentin,Peggy Parroche,Nathalie Degallaix,Carole Belanger,Pascal Birman,Dean Hum,Bart Staels,Scott L. Friedman,Stephen A. Harrison,Rohit Loomba,Arun J. Sanyal,Vlad Ratziu,Robert Walczak

HEPATOLOGY（2019）

引用0浏览0引用

TYPE 2 DIABETES AS A RISK FACTOR FOR NASH AND FIBROSIS IN A COHORT OF 2363 PATIENTS WITH SUSPICION OF NAFLD: USE OF NIS4 FOR IDENTIFICATION OF AT-RISK NASH IN DIABETIC PATIENTS

Remy Hanf,Vlad Ratziu,Sven M. Francque,Stephen A. Harrison,Quentin M. Anstee,Alice Roudot,John Brozek,Yacine Hajji,Sophie Megnien,Suneil Hosmane,Dean Hum,Pascal Birman,Pierre Chaumat,Arun J. Sanyal

HEPATOLOGY（2019）

引用0浏览0引用

LBO-02-Elafibranor, a Peroxisome Proliferator-Activted Receptor Alpha and Delta Agonist Demonstrates Favourable Efficacy and Safety in Patients with Primary Biliary Cholangitis and Inadequate Response to Ursodeoxycholic Acid Treatment

Schattenberg Joern,Albert Pares, Kris V. Kowdley,Michael Heneghan,Stephen Caldwell,Daniel Pratt,Alan Bonder,Gideon M. Hirschfield, M. B. Bchir,Cynthia Levy,John Vierling,David Jones,Sophie Megnien,Remy Hanf,David Magrez,Pascal Birman,Velimir Luketic

JOURNAL OF HEPATOLOGYno. 1 (2019): E128-E128

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn